GC Biopharma Corp. (KRX:006280)
South Korea · Delayed Price · Currency is KRW 134,300
+4,600 (3.55%)
At close: Nov 26, 2025
GC Biopharma Market Cap
GC Biopharma has a market cap or net worth of 1.53 trillion as of November 26, 2025. Its market cap has decreased by -15.80% in one year.
Market Cap
1.53T
Enterprise Value
2.68T
Revenue
1.93T
Ranking
n/a
PE Ratio
27.24
Stock Price
134,300.00
Market Cap Chart
Since August 29, 1995, GC Biopharma's market cap has increased from 29.09B to 1.53T, an increase of 5,169.90%. That is a compound annual growth rate of 14.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 1.53T | -25.18% |
| Dec 30, 2024 | 2.05T | 43.03% |
| Dec 28, 2023 | 1.43T | -3.09% |
| Dec 29, 2022 | 1.48T | -40.60% |
| Dec 30, 2021 | 2.49T | -46.31% |
| Dec 30, 2020 | 4.63T | 206.42% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.43T |
| Celltrion | 41.00T |
| ALTEOGEN | 27.70T |
| SK Biopharmaceuticals | 10.10T |
| ABL Bio | 9.56T |
| Yuhan | 8.91T |
| Peptron | 7.43T |
| LigaChem Biosciences | 6.30T |